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Abstract
Background: The nosocomial acquisition of Candida albicans is a growing concern in intensive care
units (ICUs) and understanding the route of contamination is relevant for infection control
guidelines.
Methods: To analyze whether there is a specific ecology for any given hospital, we genotyped C.
albicans isolates of the ICU of Versailles hospital (Hospital A) and compared the results with those
previously obtained in another ICU in Henri Mondor hospital (Hospital B) using three polymorphic
microsatellite markers (PMM).
Results: Among 36 patients with at least one positive culture for C. albicans, 26 had a specific
multilocus genotype, two shared a common multilocus genotype, and 8 had the most common
multilocus genotype found in the general population. The time interval between periods of
hospitalization between patients with common genotypes differed by 13 to 78 days, thus supporting
a lack of direct contamination. To confirm this hypothesis, the multilocus genotypic distributions
of the three PMM were compared between the two hospitals. No statistically significant difference
was observed. Multiple correspondences analysis did not indicate the association of a multilocus
genotypic distribution with any given hospital.
Conclusion: The present epidemiological study supports the conclusions that each patient
harbours his/her own isolate, and that nosocomial transmission is not common in any given ICU.
This study also supports the usefulness and practicability of PMM for studying the epidemiology of
C. albicans.
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Candida infections are a growing concern in patients hos-
pitalized in intensive care units (ICUs) [1]. Among the
yeasts involved, C. albicans is still predominant in ICUs,
accounting for 55% of yeast bloodstream infections [2,3].
Most of these infections are nosocomial, which raises the
issue of their prevention. Understanding the route of con-
tamination is of utmost importance in order to imple-
ment adequate preventive guidelines.
Genotyping is an approach that can be used to detect
cross-contamination. Several genotyping techniques have
been reported [4]. Among them, polymorphic microsatel-
lite markers (PMM) have a high discriminatory power and
a high throughput when fluorogenic primers and an auto-
mated sequencer are used for analysis[5,6]. The data are
computerizable and can be compared.
In a previous study on an ICU [7], we used genotyping to
show that cross-contamination with C. albicans was
unlikely and that most of the patients were colonized with
their own strain. The aim of the present study was to deter-
mine whether this finding was specific or could be gener-
alized to another ICU in another hospital. Moreover, if a
nosocomial acquisition occurs in a given hospital, a C.
albicans population specific to that hospital is expected.
Therefore, we studied the genotypes of C. albicans isolates
of a different ICU from a new hospital and compared the
results with those previously reported to detect potential
hospital-specific populations. The genotyping was per-
formed using three PMM known to have a discriminatory
power of 0.97 [5].
Methods
Study populations
The study was conducted in the ICU of Versailles hospital,
referred to as Hospital A, located southwest of Paris, and
the results were compared to those obtained in Henri
Mondor hospital, referred to as Hospital B, located south-
east of Paris, forty kilometres from Hospital A.
The ICU of Hospital A (18-bed ward) treats both medical
and surgical patients whereas the ICU of Hospital B (16-
bed ward) has only surgical patients. Patients above 18
years of age and at high risk for Candida infection were eli-
gible for the study. The criteria for inclusion were recent
abdominal surgery (<24 hours), gastrointestinal perfora-
tion or anastomotic leakages, urologic tract surgery and/or
broad-spectrum therapy for more than eight days [7]. The
following information was recorded for each patient: age,
sex, new Simplified Acute Physiology Score (SAPS II) [8],
presence of diabetes, immunodepression, wide-spectrum
antibiotic therapy, orally administered amphotericin B,
presence of arterial or central venous catheter, transfusion
requirement, total parenteral nutrition, type of surgery
and length of ICU stay. The Comité Consultatif de Protec-
tion des Personnes dans la Recherche Biomédicale of each
hospital confirmed that no ethical approval was required
since this observational study did not modify current
diagnostic or therapeutic strategies. Written or oral
informed consent was obtained from patients or from
their relatives.
Sampling
In both hospitals, patients were sampled for colonization
at entry in the ICU and then once weekly. The sampling
consisted of skin and mouth swabs, urine, stools and tra-
cheal aspirations. Clinical specimens were cultured on
chromogenic medium for 48 hours at 37°C. All green col-
onies (CHROMagar® Candida for Hospital A) and blue
colonies (Candida ID®, BioMérieux for Hospital B were
identified as C. albicans. The others colonies were identi-
fied using commercially available strips (Api 20C®,
BioMérieux in Hospital A or ATB ID32C®, BioMérieux in
Hospital B) together with micromorphological analysis
on rice-extract agar (Becton Dickinson). One colony per
sample was put into 1 ml of 10% glycerol and frozen at -
80°C until PCR analysis.
Microsatellite analysis
The surface of the C. albicans frozen aliquots was scraped
with a loop and the material obtained was seeded on Sab-
ouraud medium. After 24 h, one colony was directly sus-
pended in 100 µl of sterile water and boiled to free DNA.
After centrifugation for 3 minutes at 2000 × g, 2 µl of the
supernatant was used to amplify three polymorphic loci
named "CDC3", "EF3" and "HIS3" after the genes they are
located closest to. Primers were designed to amplify the
microsatellite markers and one primer of each set was 5'-
labeled with different dyes as previously described [5]. In
Hospital A, the PCR products were run in capillary and
read using a 310 automated sequencer (Applied Biosys-
tems). The data were stored and analyzed using the 372
GeneScan software (Applied Biosystems).
The 372 GeneScan software automatically calculates the
PCR fragment length according to the internal standard
and gives fractional numbers. To check the reproducibility
of the technique, we tested the B311 reference strain in ten
separate experiments. This strain is heterozygous for the
three markers and the length in base pairs (bp) of each
allele is known [5]. The standard deviation was +/- 0.20
bp for CDC3, +/- 0.24 for EF3, and +/- 0.42 for HIS3. To
assign a specific length to a PCR fragment, we systemati-
cally tested the B311 strain in all the PCR runs. All the PCR
results were aligned with this reference strain. Therefore,
each allele was named according to the length in bp of the
amplified fragment after the alignment with the reference
strain. When several isolates were available for a given
patient, all the profiles were also aligned to check theirPage 2 of 8
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nal for a given locus, we considered that the isolates were
homozygous for this locus [9].
Comparaison of PMM analysis between the two hospitals
In Hospital A, the PCR products were run in capillary and
read using a 370 automated sequencer (Applied Biosys-
tems). For Hospital B [7], we ran the PCR products on a
36-cm long acrylamide urea gel and read the signals using
a 377 automated sequencer (Applied Biosystems). After
analysis by the 372 GeneScan software (Applied Biosys-
tems), we were obliged to make some corrections because
of the different automated sequencers used in each place.
The differences observed between the 377 – 310 sequenc-
ers for 6 reference strains (Ca 4918, IP1877/89, IP996/69,
IP1880/89, H12, B311) were 0.4 nucleotide for CDC3,
2.4 nucleotides for EF3 and one nucleotide for HIS3.
Therefore, using the B311 strain ran in each series, we cal-
culated the differences between the length obtained with
the 310 sequencer and that calculated with the 377
sequencer and reported in previous publications [5]. We
added to each allele of each locus the difference calculated
to obtain comparative results. As described above, each
profile was compared with the B311 strain profile and the
length in base pairs was given according to the known
length of the B311 alleles.
Statistical analysis
Two kinds of statistical analysis were used to compare
Hospital A and B's populations: the genotypic differentia-
tion test called the G test and a multiple correspondence
analysis (MCA). The G test analyzes the diversity of dip-
loid populations on multi-loci where multi-allelic possi-
bilities exist and tests the null hypothesis that the
distribution is identical across populations [10]. A likeli-
hood test of the observations is performed and the result
is given by a probability P based on a Fischer's test. If P >
0.05, the compared populations are considered as similar.
This test is suitable for molecular markers such as PMM in
diploid populations, with a high level of genetic diversity,
when the loci can be considered independent [11]. The
data were coded and analyzed using the GenePop soft-
ware version 3.4 June 2003 [12].
A cluster analysis between the two populations was per-
formed by MCA which is an ordination technique. MCA
is a type of Correspondence Analysis (CA) which consid-
erably expands the scope of Principal Components Anal-
ysis (PCA). The percentage inertia explained by axes takes
the place of the percentage variance of PCA. PMM data can
be coded by 1 (presence) or 0 (absence) for each of the
possible allele. Such coding leads to complete disjunctive
data used in the MCA. One byproduct is that the row and
column projections in the new space may both be plotted
on the same output graphic presentations. For our analy-
sis, only the six first axes were considered for explaining
the contingency table variability. Scatter plots were cho-
sen for a graphic representation. They were centered in the
first two axes. This analysis was performed using the
XLSTAT (version 7.5) software package [13]. A hierarchi-
cal classification by a neighbor-joining with the squared
Euclidian distances was determined from the six first axes
of the MCA.
Results
In Hospital A, 1424 patients were hospitalized from 1st
February 2000 to 31st January 2002, and 60 patients were
included. Among them, 56 patients (93%) had at least
one sample that was positive for Candida sp. For 11 of
them, the culture was positive as early as the first day of
hospitalization in the ICU. The 45 other patients had pos-
itive samples after a minimum of 72 hours. In Hospital B,
303 patients were hospitalized from 1st November 1999
to 31st October 2000, and 94 patients were included.
Among them, 43 patients (46%) had at least one positive
sample in culture and 36 had positive samples after a min-
imum of 72 hours. Table 1 lists the demographic data and
the main characteristics of the patients in the two hospi-
tals who acquired any Candida sp colonization after 72
hours of hospitalization. The percentage of acquisition
after 72 h was 80.3% (45/56) in Hospital A and 83.7%
(36/43) in Hospital B. The number of positive cultures for
Candida spp. was 156 out of 333 (47%) specimens recov-
ered in Hospital A. The figure was lower in Hospital B
where 167 out of the 1126 (15%) samples were culture
positive. Despite this finding, there was no significant dif-
ference in the distribution of Candida species (data not
shown).
In Hospital A, 82 isolates from different anatomical sites
(Table 2) were genotyped from the 36 patients with at
least one positive culture for C. albicans. The genotype was
identical for a given patient whatever the anatomical site.
Only one patient sequentially harboured two different
genotypes in the same anatomical site (see below). In
Hospital B, 122 C. albicans isolates from different anatom-
ical sites (Table 2) from 30 patients had been genotyped
[5].
In Hospital A, 36 patients had at least one positive culture
of C. albicans and 19 patients had serial C. albicans iso-
lates. Of these 19 patients, only one patient had two dif-
ferent genotypes of C. albicans. The first genotype was
specific for the patient while the second genotype,
obtained 8 days later, was a genotype found in other
patients. Nevertheless, we kept both genotypes of this
patient for further analysis. Among these 36 patients, 26
(72%) had a specific genotype, 8 (22%) shared the multi-
locus genotype characterized by CDC3: 117–125; EF3:
126–135; HIS3: 162-162 whose the frequency is 17%Page 3 of 8
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(6%) shared another identical genotype (CDC3: 117–
125; EF3: 130–131; HIS3: 162-162). None of the 8
patients sharing the most common multilocus genotype
stayed in the ICU over the same period of time, the time
interval between the dates of hospitalization in the ICU
ranging from 28 to 78 days. The stay of the other 2
patients differed by an interval of 13 days. In Hospital B,
the most common multilocus genotype had been found
in three (10%) out of 30 patients whose stay in the ICU
differed by 7 to 96 days.
Therefore, 37 genotypes from 36 different patients in Hos-
pital A and 30 genotypes from 30 different patients in
Hospital B were available for comparison. The allelic fre-
quencies were not statistically different for 34 of the 38
different alleles observed. Table 3 reports the multilocus
genotypes of the C. albicans isolates observed in the two
hospitals. With the genotypic differentiation, the pairwise
analysis across the two populations suggested that the
populations were not significantly different (P > 0.05) for
the three PMM: CDC3 (P = 0.12), EF3 (P = 0.25) and HIS3
(P = 0.12).
The isolates were also analyzed by MCA according to their
multilocus genotype. MCA produced a multidimensional
representation of the data, which were reduced in plane
for convenience. The two first factor axes corresponding to
the percentage of the total inertia of 7.56% and 7.29%
respectively are shown on Figure 1. Both populations of
Hospital A and B are superimposable on this representa-
tion without presenting clusters, except for two particular
Table 2: Source of the 82 C. albicans genotyped isolates from 36 patients in Hospital A and the 122 C albicans genotyped isolates from 
30 patients in Hospital B.
No (%) of positive specimens
Clinical sample Hospital A Hospital B P
Number % Number %
Mouth, skin and superficial surgical wounds 38 46.3 1 0.8 0.001*
Peritoneal fluid, abscess, drain effluent and bile 3 3.6 50 41 0.001*
Stools and gastric secretions 15 18.3 18 14.7 0.350
Urinary tract 11 13.4 15 12.3 0.498
Respiratory tract 15 18.3 34 27.8 0.141
Blood 0 0.0 2 1.6 0.361
Central venous catheter 0 0.0 2 1.6 0.361
Total 82 100.0 122 100.0
* P < 0.05: significant differences. (P calculated by a Fisher's exact test).
Table 1: Main characteristics of the patients who acquired any Candida sp colonization after 72 hours of hospitalization in Hospital A 
(45/56, i;e. 80.3%) and in Hospital B (36/43, i.e; 83.7%).
Patient characteristics Hospital A n = 45 (%) Hospital B n = 36 (%) P
Age (years) mean ± SD 66.4 ± 15.4 62.6 ± 16.4 0.57
Sex ratio (M/F) 25/20 23/13 0.42
SAPS II score: mean points ± SD 45.5 ± 14 37.5 ± 14.5 0.19
Diabetes 4 (8.9) 6 (16.7) 0.28
Immunodepression 17 (37.8) 9 (25.0) 0.26
Previous administration of antibiotics 43 (95.6) 26 (72.2) 0.25
Oral amphotericin B 0 32 (88.9) 0.001*
Central venous catheter 37 (82.2) 34 (94.4) 0.40
Radial artery catheter 21 (46.7) 31 (86.1) 0.06
Transfusion requirements 17 (37.8) 29 (80.6) 0.03*
Total parenteral nutrition 15 (33.3) 27 (75.0) 0.03*
Abdominal surgery 11 (24.4) 21 (57.9) 0.03*
Liver transplant 0 3 (8.3) 0.10
Length of stay: median days (25th-75th percentiles) 21 (11–53) 31 (14.0–55.5) 0.07
*: statistically significant difference. P calculated by a Fisher's exact test.Page 4 of 8
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Table 3: Multilocus genotypes of the C. albicans isolates of the two hospitals studied.
CDC3 locus EF3 locus HIS3 locus number of isolates
Allele 1 Allele 2 Allele 1 Allele 2 Allele 1 Allele 2 Hospital A (n= 37) Hospital B (n = 30)
113 117 130 136 150 162 0 3
113 117 130 136 162 162 1 1
113 117 136 136 150 162 1 0
113 117 136 136 162 162 1 0
113 117 136 142 158 158 1 0
117 117 126 135 162 162 0 1
117 117 130 136 150 162 0 1
117 117 130 136 154 194 0 1
117 117 133 140 154 154 0 1
117 117 133 144 154 178 0 1
117 117 133 144 154 186 0 1
117 117 136 136 162 162 1 0
117 117 136 144 154 154 1 0
117 117 137 139 182 182 0 1
117 121 131 130 162 186 1 0
117 121 132 135 154 162 1 0
117 121 133 136 154 154 0 1
117 121 136 139 154 154 1 0
117 125 126 126 162 162 1 0
117 125 126 126 162 162 0 1
117 125 126 135 154 162 1 0
117 125 126 135 154 166 1 0
117 125 126 135 158 158 1 0
117 125 126 135 162 162 8 3
117 125 126 135 170 218 0 1
117 125 126 135 202 210 1 0
117 125 126 135 210 218 0 1
117 125 126 135 218 230 1 0
117 125 130 130 162 162 1 1
117 125 130 144 154 154 0 1
117 125 131 130 162 162 2 0
117 125 131 131 162 162 0 1
117 125 131 131 162 190 0 1
117 125 131 131 166 166 0 2
117 125 133 144 154 182 0 1
117 125 136 139 154 154 1 0
117 129 136 146 154 154 0 1
121 121 136 136 154 154 1 0
121 125 130 144 154 154 1 0
121 125 130 144 154 166 1 0
121 125 144 144 174 174 1 0
121 125 145 150 166 174 1 0
125 125 126 135 162 162 1 0
125 125 130 144 154 154 1 0
125 125 130 144 154 166 1 0
125 125 130 145 154 166 0 1
125 125 131 139 194 198 0 1
125 125 136 139 150 150 1 0
125 129 130 144 154 154 1 0
129 129 136 141 150 162 0 2
BMC Infectious Diseases 2006, 6:162 http://www.biomedcentral.com/1471-2334/6/162Hospital A multilocus genotypes (A31 and A32 on figure
1B). We determined that only the six first axes (a range of
inertia from about 7.6 to 5.1%) present at least one signif-
icant correlation (t-test) with the initial variables. To con-
firm that the two populations were superimposed in all
axes, we performed a hierarchical classification by a
neighbor-joining with the squared Euclidian distances
determined from the six first axes of the MCA. The corre-
sponding unrooted tree is shown on Figure 2. We
observed that independently of the origin of the multilo-
cus genotypes, both populations were distributed in all
branches of the tree without discriminate some clusters.
No association of a genotype with a particular Hospital
could be detected.
Discussion
The aim of the present study was to compare the geno-
types of C. albicans in two ICUs of two different hospitals
to determine whether or not cross-contamination occurs.
In Hospital B, a previous study had concluded that there
was a low probability of cross contamination between
patients [7]. This was confirmed in the present study in
Hospital A. Among 36 patients, 26 had a specific C. albi-
cans multilocus genotype and, once colonized, the patient
usually kept the same genotypes whatever the anatomical
site. However, eight patients shared a multilocus genotype
which is the most common multilocus genotype among
independent isolates [5]. The probability of cross-contam-
ination was low given that they were not hospitalized at
the same time in the ICU. Fomites might have had a res-
ervoir role. However, in ICUs, the cleaning procedures
between patients exclude this possibility. We cannot rule
out that a medical staff member might have served as a
common contaminator. However, the most common
shared multilocus genotype also belongs to the most com-
mon genotype in the general population, which
accounted for 17% of 100 unrelated C albicans isolates [5].
The fact that some genotypes are more frequent than oth-
ers has already been reported for C. albicans by other
authors using PMM [6,14-16]. This may be due to the 0.97
discriminatory power of the present PMM and can be
solved by using other PMM [6] to increase the discrimina-
tory power or by using another typing method such as
MLST [17]. This may also be due to the lack of a sexual
cycle in C. albicans and the expansion of some clones [18].
Similarities were found regarding the epidemiology of C.
albicans, i.e. that most fungal infections that arise in an
ICU are caused by unrelated strains, although there were
differences between the two hospitals which could have
led to less similarities. For instance, the ICU of Hospital A
treats medical and surgical patients. In contrast, Hospital
B recruits only surgical patients, deemed to be more sus-
ceptible to infections since they are more immunocom-
promised (liver transplant, pancreatitis) or have
undergone more invasive procedures. What was in fact
surprising was the vast difference in the percentage of pos-
itive culture between both hospitals, 47% (156/333) in
Hospital A versus 15% (167/1126) in Hospital B. The role
of the different media used for fungal growth seems
unlikely. An explanation could be could be the role of
amphotericin B prophylaxis, implemented in Hospital B
only, which could have hampered yeast growth. Other
studies have reported similar differences in yeast coloniza-
tion between 50% [1] and 90% [19]. This underlines the
difficulties in standardizing clinical specimens and the
microbiological procedures. However, despite these dif-
ferences, the percentage of patients exhibiting a C. albicans
colonization after 72 h was similar between the two hos-
pitals (Table 1) and the species distribution was also sim-
ilar.
The second point of our study was to determine whether
there was a C. albicans population specific to a given hos-
pital, which might have suggested a nosocomial transmis-
sion or a difference in the patient population
hospitalized. The G test and the MCA of PMM genotypes
concluded with the absence of a C. albicans population
specific to a given hospital (Figure 1A and 1B). Using the
moderately repetitive sequence Ca3 to fingerprint C. albi-
cans isolates in two distant hospitals in New Zealand [20],
the authors have provided indirect evidence of nosoco-
Multiple correspondences analysis for the 37 Hospital A mul-tilocus genotypes and th  30 Hospital B multilocus genotypesFigure 1
Multiple correspondences analysis for the 37 Hospital A mul-
tilocus genotypes and the 30 Hospital B multilocus geno-
types. The projection in the plane defined by the two most 
informative axes is shown (axis 1 variance: 7.56%; axis 2 vari-
ance: 7.29%). Although different, some multilocus genotypes 
are superimposble because of the projection on the plane. 
Green spots: Hospital A genotypes; blue spots: Hospital B 
genotypes; red spots: commun genotypes between the two 
hospitals.
Axis 2
Axis 1Page 6 of 8
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one hospital but not the other. Interestingly, these results
were obtained under conditions in which no candidiasis
outbreak occurred in either hospital, as was the case in our
study. Therefore, more systematic screening to investigate
C. albicans populations in ICUs might suggest intra-hospi-
tal acquisition and lead to reinforcement of clinical proce-
dures. Of course, when an outbreak occurs, the
genotyping of the C. albicans isolates can demonstrate the
exogenous acquisition and should lead to preventive
measures [21].
The PMM analysis produces computerizable data. How-
ever, technical issues should be pointed out since different
migration techniques (acrylamide gel versus capillary)
and not genome instability led to different allele sizes
from the same genotype. The lengths of the PCR frag-
ments and their secondary structures probably interfered
with the migration [22]. This should be taken into consid-
eration when comparing results between different labora-
tories, especially when the lengths of the PCR fragments
differ in only one or two bases. Nevertheless, this short-
coming does not change the multilocus genotypes and the
discriminatory power does not depend on the migration
technique used. Agreement between laboratories should
be achieved by using reference strains with known allelic
lengths. Despite very few limitations, the PMM technique
is well-designed for screening large number of isolates
with limited workload. The same technique can be advan-
tageously designed for the study of other yeasts, especially
C. glabrata [23] which is the second leading species
encountered in ICUs.
Conclusion
The present study reinforces previous statements obtained
from a single hospital supporting the fact that patients
Unrooted tree obtained after hierarchical classification by a neighbor-joining with the squared Euclidian distances determined from th  six first axes of th  multiple correspondence analysisFigure 2
Unrooted tree obtained after hierarchical classification by a neighbor-joining with the squared Euclidian distances determined 
from the six first axes of the multiple correspondence analysis. Same colour code as in Figure 2. Multilocus genotypes numbers 
are arbitrary.Page 7 of 8
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harbour their own C. albicans isolate [7,24]. We also
found that there was no genotype specific to any given
hospital, thus reinforcing the hypothesis that nosocomial
transmission exceptionally occurs in patients hospitalized
in the ICU. Therefore, attempts aimed at preventing C.
albicans colonization should focus on controlling the risk
factors rather than on limiting cross-contamination as this
yeast rarely appears responsible for cross-contamination
between patients in the same ward.
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